Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Prefrontal dysfunction and treatment response in geriatric depression.

Kalayam B, Alexopoulos GS.

Arch Gen Psychiatry. 1999 Aug;56(8):713-8.

PMID:
10435605
2.

Executive dysfunction and long-term outcomes of geriatric depression.

Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J.

Arch Gen Psychiatry. 2000 Mar;57(3):285-90.

PMID:
10711915
3.

Executive dysfunction and the course of geriatric depression.

Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning-Dixon F.

Biol Psychiatry. 2005 Aug 1;58(3):204-10.

PMID:
16018984
4.

[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].

Mouchabac S, Ferreri M, Cabanac F, Bitton M.

Encephale. 2003 Sep-Oct;29(5):438-44. French.

PMID:
14615693
5.

[Depression and frontal dysfunction: risks for the elderly?].

Thomas P, Hazif Thomas C, Billon R, Peix R, Faugeron P, Clément JP.

Encephale. 2009 Sep;35(4):361-9. doi: 10.1016/j.encep.2008.03.012. Epub 2008 Oct 1. French.

PMID:
19748373
6.

Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.

Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Höschl C.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):319-25. Epub 2006 Aug 4.

PMID:
16889798
7.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
8.

Recovery in geriatric depression.

Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Feder M, Einhorn A, Rosendahl E.

Arch Gen Psychiatry. 1996 Apr;53(4):305-12.

PMID:
8634008
9.

HF-rTMS treatment decreases psychomotor retardation in medication-resistant melancholic depression.

Baeken C, De Raedt R, Santermans L, Zeeuws D, Vanderhasselt MA, Meers M, Vanderbruggen N.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):684-7. doi: 10.1016/j.pnpbp.2010.03.021. Epub 2010 Mar 20.

PMID:
20307619
10.

The relationship of personality disorders to treatment outcome in depressed outpatients.

Mulder RT, Joyce PR, Luty SE.

J Clin Psychiatry. 2003 Mar;64(3):259-64.

PMID:
12716266
11.
12.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
13.

Sertraline treatment of elderly patients with depression and cognitive impairment.

Devanand DP, Pelton GH, Marston K, Camacho Y, Roose SP, Stern Y, Sackeim HA.

Int J Geriatr Psychiatry. 2003 Feb;18(2):123-30.

PMID:
12571820
14.
15.

A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

Mazeh D, Shahal B, Aviv A, Zemishlani H, Barak Y.

Int Clin Psychopharmacol. 2007 Nov;22(6):371-5.

PMID:
17917556
16.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
17.

A controlled trial of daily left prefrontal cortex TMS for treating depression.

George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, Arana GW, Risch SC, Ballenger JC.

Biol Psychiatry. 2000 Nov 15;48(10):962-70.

PMID:
11082469
18.

Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study.

Steinberg M, Munro CA, Samus Q, V Rabins P, Brandt J, Lyketsos CG.

Int J Geriatr Psychiatry. 2004 Feb;19(2):144-50.

PMID:
14758580
19.

Which depressed patients respond to nefazodone and when?

Trivedi MH, Rush AJ, Pan JY, Carmody TJ.

J Clin Psychiatry. 2001 Mar;62(3):158-63.

PMID:
11305700
20.

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.

Arch Gen Psychiatry. 2004 Dec;61(12):1235-44.

PMID:
15583115

Supplemental Content

Support Center